PUNE, India, November 10, 2015 /PRNewswire/ --
According to a new market research report "Hemodialysis & Peritoneal Dialysis Market Products (Machine, Dialyzer, Bloodlines, Concentrates, Catheters, Transfer Sets, Water Treatment Systems, & Services), Modality (Nocturnal, APD, & CAPD), End-users (In-center & Home) - Global Forecast to 2020", published by MarketsandMarkets, The market is estimated at USD 69.45 Billion in 2015 and is poised to grow at a CAGR of 6.2% during the forecast period, to reach USD 93.83 Billion by 2020.
Browse 139 market data Tables with 82 Figures across 295 Pages and in-depth TOC on "Hemodialysis & Peritoneal Dialysis Market"
Early buyers will receive 10% customization on this report.
The market report analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Asia-Pacific, Europe, and Rest of the World. This report studies the global dialysis products and services market over the forecast period of 2015 to 2020.
The global dialysis market is categorized into two broad segments, namely, hemodialysis and peritoneal dialysis. The hemodialysis (products and services) market has been further classified into, conventional hemodialysis, short daily hemodialysis, and nocturnal hemodialysis; whereas the peritoneal dialysis (products and services) market has been further classified into, continuous ambulatory peritoneal dialysis (CAPD) and ambulatory peritoneal dialysis (APD). Furthermore, based on the type of end users, the global dialysis market has been segmented into in-center dialysis and home dialysis.
A number of factors such as the increasing number of end stage renal disease (ESRD) patients and rising prevalence of diabetes and hypertension are stimulating the demand for dialysis treatment. Furthermore, growth in aging population, low preference of patients for kidney transplantation, technological advancements, and substantial government healthcare expenditure on the treatment of ESRD are adding to the growth prospects of dialysis products and services market. The evolution of new dialysis modalities, growth opportunities in emerging markets, increasing number of dialysis centers, and growing adoption of home dialysis treatment offer significant growth opportunities for leading players active in the global dialysis market.
Ask for PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=1279
As of 2015, North America (comprising the U.S. and Canada) holds the largest share (~36.9%) of the global dialysis market. A number of factors such as the high number of dialysis centers, rapid adoption rate of advanced technologies, increasing prevalence of diabetes and hypertension, structured reimbursement system, and availability of skilled nephrologists and well equipped dialysis centers/hospitals are driving the growth of the dialysis market in North America. However, the Asia-Pacific dialysis market is expected to witness the highest growth (~9.7%) in the forecast period. Factors such as the presence of a large patient population base, increasing number of private and public owned dialysis centers, improving reimbursement and insurance scenario, and increasing government initiatives are propelling the growth of the dialysis market in the Asia-Pacific region.
The major players in the global Dialysis Market include Fresenius Medical Care AG & Co. KGaA (Germany), DaVita Healthcare Partners, Inc. (U.S.), Baxter International, Inc. (U.S.), B. Braun Melsungen AG (Germany), Nipro Corporation (Japan), Diaverum Deutschland GmbH (Germany), Nikkiso Co. Ltd. (Japan), Asahi Kasei Corporation (Japan), and NxStage Medical, Inc. (U.S.).
Browse Related Reports:
Continuous Renal Replacement Therapy (CRRT) Market by Products (System, Disposables (Hemofilters & Bloodlines), & Dialysate/Replacement Fluids), Modality (SCUF, CVVH, CVVHD, CVVHDF) and Geography - Regional Adoption and Global Forecasts to 2020
Apheresis Market by Application (Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Leukapheresis, and Photopheresis), Procedure (Therapeutic Apheresis, Donor Apheresis/Apheresis Blood Donation), Technology & by Product - Global Forecast to 2020
MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets